bf/NYSE:ELV_icon.png

COM:ELEVANCEHEALTH

Elevance Health

  • Stock

USD

Last Close

403.60

22/11 21:00

Market Cap

124.25B

Beta: -

Volume Today

1.18M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-17.22B
-
-17.54B
1.86%
-17.53B
0.10%
-17.30B
1.28%
-17.54B
1.39%
-21.64B
23.38%
-27.30B
26.14%
-31.69B
16.08%
-36.41B
14.88%
-24.93B
31.52%
-5.69B
77.18%
average payables
9.43B
-
10.03B
6.39%
10.70B
6.65%
11.40B
6.52%
12.46B
9.33%
12.71B
2.03%
12.73B
0.09%
14.95B
17.44%
17.67B
18.23%
19.56B
10.69%
10.32B
47.26%
average receivables
5.06B
-
6.26B
23.80%
7.30B
16.56%
7.95B
9.01%
8.68B
9.13%
9.05B
4.29%
9.93B
9.72%
10.76B
8.29%
12.20B
13.42%
14.74B
20.85%
8.02B
45.58%
book value per share
84.44
-
90.45
7.12%
88.21
2.48%
95.17
7.89%
103.49
8.75%
113.80
9.96%
124.18
9.12%
132.37
6.60%
147.91
11.74%
151.28
2.28%
165.57
9.45%
capex per share
-2.07
-
-2.34
12.86%
-2.31
1.25%
-2.21
4.12%
-3.09
39.45%
-4.82
56.09%
-4.22
12.48%
-4.07
3.42%
-4.46
9.52%
-4.80
7.66%
-5.46
13.73%
capex to depreciation
-0.67
-
-0.74
10.19%
-0.66
9.81%
-0.64
3.62%
-0.89
38.66%
-1.07
20.78%
-0.95
11.32%
-0.88
6.92%
-0.83
5.64%
-0.69
17.62%
-0.74
7.99%
capex to operating cash flow
-0.20
-
-0.19
6.53%
-0.15
21.24%
-0.18
24.33%
-0.19
3.68%
-0.32
67.17%
-0.18
43.71%
-0.10
46.24%
-0.13
36.05%
-0.14
5.54%
-0.16
17.22%
capex to revenue
-0.01
-
-0.01
0.80%
-0.01
10.20%
-0.01
9.71%
-0.01
27.62%
-0.01
49.44%
-0.01
21.20%
-0.01
18.93%
-0.01
6.42%
-0.01
6.17%
-0.01
2.82%
cash per share
63.55
-
73.25
15.27%
72.93
0.44%
80.59
10.49%
82.02
1.78%
82.32
0.37%
96.38
17.08%
116.32
20.69%
127.76
9.83%
138.91
8.73%
153.20
10.28%
days of inventory on hand
-5.32K
-
-1.40K
73.71%
-1.29K
7.89%
-318.69
75.28%
days payables outstanding
2.39K
-
687.03
71.25%
619.38
9.85%
577.70
6.73%
days sales outstanding
27.07
-
35.83
32.35%
33.85
5.52%
36.84
8.84%
35.65
3.25%
36.90
3.51%
36.96
0.17%
32.82
11.20%
35.38
7.81%
37.40
5.69%
debt to assets
0.24
-
0.24
0.36%
0.26
5.29%
0.24
5.99%
0.28
16.93%
0.27
5.00%
0.26
3.39%
0.23
10.80%
0.24
2.32%
0.23
0.87%
0.23
1.72%
debt to equity
0.59
-
0.62
6.77%
0.69
10.19%
0.63
8.99%
0.75
20.03%
0.67
10.50%
0.63
5.95%
0.60
4.67%
0.64
5.83%
0.66
3.99%
0.64
3.78%
dividend yield
0.02
-
0.01
13.71%
0.02
26.34%
0.02
0.07%
0.01
32.18%
0.01
3.70%
0.01
10.02%
0.01
11.76%
0.01
17.54%
0.01
2.19%
0.01
24.83%
earnings yield
0.09
-
0.08
17.00%
0.07
7.85%
0.07
7.32%
0.07
2.39%
0.06
14.63%
0.06
9.41%
0.06
8.86%
0.05
4.86%
0.05
9.39%
0.05
9.28%
enterprise value
40.01B
-
46.69B
16.72%
50.18B
7.46%
49.57B
1.21%
73.94B
49.17%
81.14B
9.74%
92.32B
13.77%
94.82B
2.72%
131.16B
38.32%
139.84B
6.62%
130.54B
6.65%
enterprise value over ebitda
7.68
-
8.01
4.26%
8.10
1.17%
8.01
1.18%
13.22
65.09%
11.67
11.72%
12.97
11.13%
-31.69
344.36%
-38.34
20.98%
13.58
135.43%
74.98
452.01%
ev to operating cash flow
13.11
-
13.86
5.74%
12.19
12.03%
15.47
26.89%
17.67
14.23%
21.20
20.00%
15.23
28.17%
8.87
41.75%
15.68
76.76%
16.65
6.17%
16.19
2.73%
ev to sales
0.56
-
0.63
12.22%
0.63
0.29%
0.58
7.85%
0.82
40.59%
0.88
7.28%
0.89
0.55%
0.78
12.16%
0.95
21.59%
0.89
5.61%
0.76
14.68%
free cash flow per share
8.34
-
10.23
22.70%
13.45
31.46%
9.94
26.11%
13.26
33.40%
10.44
21.22%
19.51
86.80%
38.54
97.60%
29.85
22.56%
30.20
1.16%
28.50
5.63%
free cash flow yield
0.09
-
0.08
9.79%
0.10
18.48%
0.07
28.33%
0.06
14.77%
0.04
32.51%
0.06
62.43%
0.12
85.87%
0.06
46.36%
0.06
8.58%
0.06
2.66%
graham net net
-71.15
-
-80.69
13.41%
-87.06
7.89%
-79.54
8.64%
-98.82
24.25%
-112.34
13.68%
-108.45
3.46%
-132.33
22.02%
-160.76
21.48%
-111.24
30.81%
-139.65
25.55%
graham number
127.00
-
139.66
9.97%
139.46
0.15%
141.60
1.54%
186.93
32.01%
195.67
4.67%
229.28
17.18%
233.01
1.63%
288.65
23.88%
292.32
1.27%
306.51
4.86%
income quality
1.13
-
1.31
16.62%
1.61
22.47%
1.30
19.30%
1.09
16.07%
1.02
6.29%
1.26
23.55%
2.34
85.40%
1.37
41.30%
1.40
1.69%
1.35
3.51%
intangibles to total assets
0.43
-
0.40
5.22%
0.42
3.29%
0.39
5.89%
0.39
0.24%
0.41
5.39%
0.38
8.65%
0.36
4.69%
0.36
0.26%
0.34
5.71%
0.33
3.23%
interest coverage
4.37
-
4.26
2.49%
3.92
8.01%
3.42
12.86%
6.36
86.29%
7.73
21.48%
8.02
3.78%
-5.29
165.92%
-5.92
11.92%
10.13
271.14%
-0.00
100.04%
interest debt per share
51.47
-
58.76
14.16%
63.23
7.61%
62.37
1.36%
80.72
29.42%
79.60
1.38%
81.53
2.42%
83.01
1.82%
97.74
17.74%
104.02
6.43%
110.15
5.89%
inventory turnover
-0.07
-
-0.26
280.32%
-0.28
8.56%
-1.15
304.55%
invested capital
0.59
-
0.62
6.77%
0.69
10.19%
0.63
8.99%
0.75
20.03%
0.67
10.50%
0.63
5.95%
0.60
4.67%
0.64
5.83%
0.66
3.99%
0.64
3.78%
market cap
27.10B
-
33.69B
24.35%
36.43B
8.11%
37.92B
4.10%
57.62B
51.96%
65.87B
14.31%
77.17B
17.16%
80.53B
4.36%
113.01B
40.34%
123.11B
8.94%
111.95B
9.07%
net current asset value
-5.06B
-
-5.58B
10.30%
-7.81B
39.87%
-5.67B
27.44%
-7.77B
37.17%
-13.07B
68.14%
-10.55B
19.32%
-13.28B
25.96%
-16.59B
24.90%
-10.76B
35.14%
-9.49B
11.77%
net debt to ebitda
2.48
-
2.23
10.05%
2.22
0.42%
1.88
15.24%
2.92
55.04%
2.20
24.71%
2.13
3.14%
-4.78
324.49%
-5.31
11.06%
1.62
130.62%
10.68
557.33%
net income per share
8.49
-
9.58
12.90%
9.80
2.24%
9.36
4.44%
15.01
60.25%
14.95
0.36%
18.81
25.83%
18.23
3.11%
25.04
37.34%
25.10
0.27%
25.22
0.46%
operating cash flow per share
10.41
-
12.57
20.75%
15.76
25.38%
12.15
22.89%
16.34
34.50%
15.26
6.62%
23.72
55.46%
42.62
79.65%
34.31
19.50%
35.00
2.01%
33.96
2.97%
payables turnover
0.15
-
0.53
247.78%
0.59
10.92%
0.63
7.21%
receivables turnover
13.48
-
10.19
24.44%
10.78
5.85%
9.91
8.13%
10.24
3.36%
9.89
3.39%
9.88
0.17%
11.12
12.62%
10.32
7.25%
9.76
5.38%
research and ddevelopement to revenue
return on tangible assets
0.07
-
0.07
4.62%
0.07
2.47%
0.06
12.20%
0.09
43.33%
0.09
0.37%
0.10
11.67%
0.08
17.29%
0.10
18.66%
0.09
9.43%
0.08
7.76%
revenue per share
242.17
-
275.54
13.78%
303.01
9.97%
321.76
6.19%
351.60
9.27%
367.24
4.45%
407.88
11.06%
485.91
19.13%
568.66
17.03%
652.48
14.74%
721.74
10.61%
roe
0.10
-
0.11
5.40%
0.11
4.84%
0.10
11.43%
0.14
47.36%
0.13
9.38%
0.15
15.31%
0.14
9.10%
0.17
22.92%
0.17
1.97%
0.15
8.21%
roic
0.05
-
0.04
17.28%
0.04
4.48%
0.03
9.82%
0.10
199.37%
0.09
8.13%
0.09
2.86%
-0.06
161.53%
-0.06
7.69%
0.11
279.81%
-0.00
100.04%
sales general and administrative to revenue
0.12
-
0.14
17.05%
0.14
0.93%
0.13
6.11%
0.12
5.01%
0.05
-
shareholders equity per share
84.44
-
90.45
7.12%
88.21
2.48%
95.17
7.89%
103.49
8.75%
113.80
9.96%
124.18
9.12%
132.37
6.60%
147.91
11.74%
151.28
2.28%
165.57
9.45%
stock based compensation to revenue
0.00
-
0.00
11.22%
0.00
18.11%
0.00
3.60%
0.00
2.89%
0.00
30.27%
0.00
14.97%
0.00
17.69%
0.00
20.79%
0.00
8.34%
tangible asset value
-593M
-
-788.80M
33.02%
-2.68B
239.26%
-425.70M
84.09%
-1.10B
157.62%
-970M
11.55%
2.55B
363.30%
2.10B
17.66%
1.28B
38.90%
1.70B
31.98%
3.81B
124.94%
tangible book value per share
-2.02
-
-2.94
45.50%
-10.24
248.19%
-1.61
84.24%
-4.28
165.33%
-3.87
9.69%
10.00
358.46%
8.39
16.12%
5.27
37.14%
7.07
34.07%
16.07
127.40%
working capital
13.39B
-
13.48B
0.61%
11.77B
12.66%
13.02B
10.63%
12.91B
0.87%
14.65B
13.50%
18.82B
28.50%
21.32B
13.26%
23.07B
8.21%
15.92B
30.99%
18.24B
14.55%

All numbers in USD (except ratios and percentages)